JAGX JAGX

Jaguar Health Stock Price

0.32
0.0173 (5.72%)
Upgrade to Real-Time
Afterhours (Closed)
0.32
Volume 12,922,223
Bid Price 0.32
Ask Price 0.3283
News -
Day High 0.38

Low
0.27

52 Week Range

High
3.04

Day Low 0.3215
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Jaguar Health Inc JAGX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0173 5.72% 0.32 19:59:06
Open Price Low Price High Price Close Price Prev Close
0.3603 0.3215 0.38 0.32 0.3027
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
13,761 12,922,223 $ 0.3454316 $ 4,463,744 - 0.27 - 3.04
Last Trade Time Type Quantity Stock Price Currency
19:59:06 formt 829 $ 0.32 USD

Period:

Draw Mode:

Jaguar Health Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 24.92M 77.87M 69.18M $ 4.34M $ - -1.16 -0.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 1.63M 0.30%

more financials information »

Jaguar Health News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical JAGX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.2990.380.270.28682221,288,5280.0217.02%
1 Month0.3790.38480.270.32859241,580,887-0.059-15.57%
3 Months0.67580.770.270.47487921,599,629-0.3558-52.65%
6 Months1.161.160.270.57664662,931,975-0.84-72.41%
1 Year1.673.040.271.133,247,737-1.35-80.84%
3 Years4.775.270.1851.518,639,428-4.45-93.29%
5 Years38.885224.000.1855.856,605,775-38.57-99.18%

Jaguar Health Description

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders.


Your Recent History
NASDAQ
JAGX
Jaguar Hea..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.